Zealand Pharma begins mid-stage trial for obesity drug candidate in people with type 2 diabetes
Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or obesity and type 2 diabetes.